1. The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection. Issue 4 (17th December 2020) Authors: Figueroa, MI; Camiro‐Zuñiga, A; Belaunzaran‐Zamudio, PF; Sierra Madero, J; Andrade Villanueva, J; Arribas, JR; Lama, JR; Cecchini, DM; Lopardo, G; Crabtree‐Ramírez, B; Gun, A; Patterson, P; Fink, VI; Sued, OG; Cahn, P Journal: HIV medicine Issue: Volume 22:Issue 4(2021) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Etravirine in treatment‐experienced, HIV‐1‐infected children and adolescents: 48‐week safety, efficacy and resistance analysis of the phase II PIANO study. Issue 9 (3rd March 2014) Authors: Tudor‐Williams, G; Cahn, P; Chokephaibulkit, K; Fourie, J; Karatzios, C; Dincq, S; Opsomer, M; Kakuda, TN; Nijs, S; Tambuyzer, L; Tomaka, FL; PIANO study group Journal: HIV medicine Issue: Volume 15:Issue 9(2014:Oct.) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Subgroup analysis of virological response rates with once‐ and twice‐daily darunavir/ritonavir in treatment‐experienced patients without darunavir resistance‐associated mutations in the ODIN trial. Issue 7 (10th March 2013) Authors: Sension, M; Cahn, P; Domingo, P; Hodder, S; Opsomer, M; Lathouwers, E; Van de Casteele, T; Tomaka, F Journal: HIV medicine Issue: Volume 14:Issue 7(2013:Aug.) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗